Viewing Study NCT01846793


Ignite Creation Date: 2025-12-25 @ 1:22 AM
Ignite Modification Date: 2026-02-22 @ 5:22 PM
Study NCT ID: NCT01846793
Status: COMPLETED
Last Update Posted: 2017-03-10
First Post: 2013-05-01
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase 3 Evaluation of Re-Injection of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH)(NX02-0022)
Sponsor: Nymox Corporation
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module